I think the purchase is solid (as long as we can reduce costs and turn a Net Profit where TXMD didn't even get close), but think that perhaps HALLOETTE is the product that should be off loaded. We paid Mithra $6m USD + another $1.6m USD on launch, but have what Reddit feedback (from users) suggests is a superior product.
Can we sell this? Is there any value? Or is it just another write-off in the wings?
I think the purchase is solid (as long as we can reduce costs...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.03 |
Change
-0.170(3.27%) |
Mkt cap ! $408.6M | |||
| Open | High | Low | Value | Volume |
| $5.20 | $5.21 | $5.03 | $2.804M | 555.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14654 | $5.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.14 | 3111 | 2 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| MYX (ASX) Chart |